Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death
| dc.contributor.author | Halo Azad Khidwrbagi | |
| dc.contributor.author | Smer Mutlag | |
| dc.contributor.author | Титова, Ганна Юріївна | |
| dc.date.accessioned | 2014-06-02T06:57:10Z | |
| dc.date.available | 2014-06-02T06:57:10Z | |
| dc.date.issued | 2014-05 | |
| dc.description.abstract | Compared with amoxicillin, azithromycin resulted in a statistically significant increase in mortality and arrhythmia risks on days 1 to 5, but not 6 to 10. Levofloxacin, which was predominantly dispensed for a minimum of 10 days, resulted in an increased risk throughout the 10-day period. During those researches they showed that using of azithromycin and levofloxacin they have high risk and they cause cardiac arrhythmia and later lead to death which has showed during investigation among those patients who has COPD, UTI and other pulmonary disease and have treatment by those drugs and dictate those complications as using of them. | uk_UA |
| dc.identifier.citation | Halo Azad Khidwrbagi. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death / Halo Azad Khidwrbagi, Smer Mutlag, A. Titova // 7th International Scientific Interdisciplinary Conference for medical students and young scientists, Kharkiv, May 15–16, 2014 : abstract book / Kharkiv National Medical University. – Kharkiv, 2014. – Р. 76. | uk_UA |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/6181 | |
| dc.language.iso | en | uk_UA |
| dc.subject | cardiovascular death | uk_UA |
| dc.subject | cardiac arrhythmia | uk_UA |
| dc.subject | azithromycin | uk_UA |
| dc.subject | levofloxacin | uk_UA |
| dc.title | Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death | uk_UA |
| dc.type | Thesis | uk_UA |